Ziegler T
Institut für Organische Chemie und Isotopenforschung, Universität Stuttgart, Germany.
Carbohydr Res. 1994 Sep 15;262(2):195-212. doi: 10.1016/0008-6215(94)84179-9.
The marine sponge Microciona prolifera and human coagulation factor IX (Christmas factor)-related mono- to tri-saccharide 5-aminopentyl glycosides beta-D-Gal p-R (5), beta-D-Glc pNAc-R (16), beta-D-Gal p-(1-->4)-beta-D-Glc p NAc-R (26), beta-D-Glc p NAc-(1-->3)-beta-L-Fuc p-R (39), beta-D-Glc pNAc-(1-->3)-alpha-L-Fuc p-R (43), beta-D-Gal p-(1-->4)-beta-D- Glc pNAc-(1-->3)-beta-L-Fuc p-R (45), and beta-D-Gal p-(1-->4)-beta-D-Glc p NAc-(1-->3)-alpha-L-Fuc p-R (47), where R is a 5-aminopentyloxy spacer moiety, which allowed the construction of glycoconjugates, were prepared. Thus, 3,4,6-tri-O-acetyl-2-deoxy-2-(2,2,2- trichloroethoxycarbonyl-amino)-alpha-D-glucopyranosyl trichloroacetimidate (10) and 1,3,4,6-tetra-O-acetyl-2-chloro-acetamido-2- deoxy-beta-D-glucopyranose (13) were condensed with N-Z-protected 5-amino-pentanol (2) followed by conversion of the coupling products into the corresponding N-acetylglucosamine derivatives, to give compound 16 after deblocking. Similarly, the donors 10 and 13 were coupled to position 3 of suitably protected aminopentyl beta- (32) and alpha- (37) -L-fucopyranosides, to give the disaccharides 39 and 43, respectively. Starting from lactose, O-(2,3,4,6-tetra-O-benzoyl-beta-D-galactopyranosyl)-(1-->4)-3,6-di-O- benzoyl-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-alpha-D-glu copyranosyl trichloroacetimidate (23) was prepared and used as an efficient disaccharide donor for the construction of ligand 26 from 2 and of the trisaccharide ligands 45 and 47 from fucosides 32 and 37, respectively.
制备了海洋海绵微小多管海绵和人凝血因子IX(克里斯马斯因子)相关的单糖至三糖5-氨基戊基糖苷β-D-半乳糖p-R(5)、β-D-葡萄糖pNAc-R(16)、β-D-半乳糖p-(1→4)-β-D-葡萄糖pNAc-R(26)、β-D-葡萄糖pNAc-(1→3)-β-L-岩藻糖p-R(39)、β-D-葡萄糖pNAc-(1→3)-α-L-岩藻糖p-R(43)、β-D-半乳糖p-(1→4)-β-D-葡萄糖pNAc-(1→3)-β-L-岩藻糖p-R(45)和β-D-半乳糖p-(1→4)-β-D-葡萄糖pNAc-(1→3)-α-L-岩藻糖p-R(47),其中R为5-氨基戊氧基间隔基团,这些糖苷可用于构建糖缀合物。因此,将3,4,6-三-O-乙酰基-2-脱氧-2-(2,2,2-三氯乙氧羰基氨基)-α-D-吡喃葡萄糖基三氯乙酰亚胺酯(10)和1,3,4,6-四-O-乙酰基-2-氯乙酰氨基-2-脱氧-β-D-吡喃葡萄糖(13)与N-Z保护的5-氨基戊醇(2)缩合,然后将偶联产物转化为相应的N-乙酰葡糖胺衍生物,脱保护后得到化合物16。类似地,将供体10和13与适当保护的氨基戊基β-(32)和α-(37)-L-岩藻糖苷的3位偶联,分别得到二糖39和43。从乳糖开始,制备了O-(2,3,4,6-四-O-苯甲酰基-β-D-吡喃半乳糖基)-(1→4)-3,6-二-O-苯甲酰基-2-脱氧-2-(2,2,2-三氯乙氧羰基氨基)-α-D-吡喃葡萄糖基三氯乙酰亚胺酯(23),并将其用作有效的二糖供体,分别从2构建配体26,从岩藻糖苷32和37构建三糖配体45和47。